Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: MAV, FOR, PSF, CFG

UPDATE - Media Advisory - Prime Minister's itinerary for Wednesday, March 25, 2020


OTTAWA, March 25, 2020 /CNW/ -

Note: All times local

 

Ottawa, Ontario



Private meetings.



The Prime Minister will speak with the President of Rwanda, Paul Kagame.



The Prime Minister will speak with the President of Senegal, Macky Sall.



The Prime Minister will speak with the President of South Korea, Moon Jae-in.



The Prime Minister will chair the Cabinet meeting.



Closed to media.



11:15 a.m.

The Prime Minister will address Canadians on the COVID-19 situation, and a media availability will follow.




Rideau Cottage


1 Sussex Drive




Notes for media:




  • Open coverage
  • Media are asked to arrive to the Princess Anne Entrance no later than 10:45 a.m. and to make their way to the P1 Gate once on the grounds.
  • Media wishing to cover the event must be accredited with the Parliamentary Press Gallery.
  • Journalists can dial in to listen and ask questions to the Prime Minister.
  • Participant dial-in numbers:
    Local: 613-960-7527
    Toll-free: 1-888-265-0903
    Pass code: 8895888#

 

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: